FA1-00613-1 UCLA Institute 90 81 89 90
FA1-00616-1 UC, Santa
Barbara Institute 90 81 89 70
FA1-00617-1 UC, Santa Cruz Institute 90 81 89 84
FA1-00618-1 UC, San
Francisco Institute 90 81 89 92
FA1-00619-1 USC Institute 90 81 89 80
FA1-00611-1 UC, Davis Institute 85 90 83 88
FA1-00600-1 The Buck
Age Research Center 81 85 83
FA1-00610-1 UC, Berkeley Center 80 75 80
FA1-00614-1 UC, Merced Program 72 71
"We are pleased that CIRM and the ICOC recognize the advantages of this type of collaboration and the need for a centralized location to conduct and translate research," said Edward Holmes, M.D., SDCRM's President and CEO. "This facility will enable the outstanding investigators who have and will join SDCRM to pursue the type of stem cell research that leads to breakthroughs in our understanding of human disease and where results with the greatest potential to help patients are translated into new therapies."
SDCRM will submit Part II of the Major Facility Grant Application, which contains technical information about the facility and how SDCRM's scientific program aligns with CIRM's objectives, in February. ICOC review and ultimate funding decisions will take place in April of this year.
Formed in 2005, the San Diego Consortium for Regenerative Medicine
(SDCRM) is a nonprofit organization that marshals the intellectual
resources of four world-leaders in life sciences research, including the
Burnham Institute for Medical Research, the Salk Institute for Biological
|SOURCE The San Diego Consortium for Regenerative Medicine|
Copyright©2008 PR Newswire.
All rights reserved